Skip to main content

Day: December 4, 2023

SL Green Realty Corp. Announces Annual Ordinary Dividend of $3.00 Per Share

Cash Dividend Equates to 7.5% Yield on Current Share Price NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, announced today that its board of directors has established an annual ordinary dividend on SL Green’s common stock of $3.00 per share. The ordinary dividend will continue to be paid in cash on a monthly basis. The first monthly ordinary dividend of $0.25 per share is payable on January 16, 2024, to stockholders of record at the close of business on December 29, 2023. “We believe that providing a sustainable, recurring dividend to our shareholders is a fundamental part of our business, while maintaining a focus on retained cash flow and distributing 100% of our taxable income. With the backdrop of a challenging, but improving, New York City office market...

Continue reading

Nayax Appoints New Chief Information Officer

HERZLIYA, Israel, Dec. 04, 2023 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments and loyalty platform designed to help merchants scale their business, today announced that Moshe Shmaryahu recently joined the Nayax leadership team as Chief Information Officer. Mr. Shmaryahu will lead the company’s information systems (IS) and Corporate IT, uniting the IT internal infrastructure and business applications under one roof to optimize the organization’s systems and technology. Moshe Shmaryahu, who began serving as Nayax’s Chief Information Officer last month, served for 11 years prior to this as Chief Operating Officer (COO), Senior Director of Operations and Infrastructure at the Union Bank of Israel, the sixth largest Israeli bank. From 2009-2011, Mr. Shmaryahu served...

Continue reading

SL Green and Vornado Announce 270,000-Square-Foot Lease with a Premier Financial Services Tenant at 280 Park Avenue

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), and Vornado Realty Trust (NYSE: VNO) today announced that they have signed a 15-year renewal and expansion lease with a premier financial services tenant covering 269,905 square feet on six floors at 280 Park Avenue. Spanning the entire block front of Park Avenue between 48th and 49th Streets, 280 Park Avenue is a best-in-class 1.25 million-square-foot Midtown Manhattan office building owned in joint venture between SL Green and Vornado. “This lease together with the previously announced 100,000 square foot renewal and expansion lease with one of the world’s largest sovereign wealth funds reaffirms the strength of the Park Avenue submarket,” said Glen Weiss, Executive Vice President, Office Leasing – Co-Head of Real Estate at Vornado, and Steven...

Continue reading

SL Green and Vornado Announce 270,000-Square-Foot Lease with a Premier Financial Services Tenant at 280 Park Avenue

NEW YORK, Dec. 04, 2023 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), and Vornado Realty Trust (NYSE: VNO) today announced that they have signed a 15-year renewal and expansion lease with a premier financial services tenant covering 269,905 square feet on six floors at 280 Park Avenue. Spanning the entire block front of Park Avenue between 48th and 49th Streets, 280 Park Avenue is a best-in-class 1.25 million-square-foot Midtown Manhattan office building owned in joint venture between SL Green and Vornado. “This lease together with the previously announced 100,000 square foot renewal and expansion lease with one of the world’s largest sovereign wealth funds reaffirms the strength of the Park Avenue submarket,” said Glen Weiss, Executive Vice President, Office Leasing – Co-Head of Real Estate at Vornado, and Steven...

Continue reading

HEALWELL AI Completes Acquisition of ‘Pentavere’, a Leading Healthcare AI and Data Science Company

HEALWELL completes acquisition of a majority stake of Pentavere, a healthcare artificial intelligence (AI) company who has built a best-in-class AI engine to help solve some of healthcare’s toughest data challenges. Pentavere has developed and validated leading capabilities in data structuring and abstraction; a key capability to unlocking clinical value and unmet needs for patients and providers. The Pentavere acquisition adds revenue, new pharmaceutical and life sciences customers, access to hospitals as well as growing HEALWELL’s dedicated team of AI engineers. The transaction is expected to be financially and strategically accretive and highly synergistic with HEALWELL’s strategic alliance agreement with WELL Health Technologies Corp. (“WELL”) (TSX: WELL).TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) — HEALWELL AI Inc. (“HEALWELL”...

Continue reading

Fusion Fuel Green Hosts Third Quarter 2023 Investor Update

SABUGO, Portugal, Dec. 04, 2023 (GLOBE NEWSWIRE) — Fusion Fuel Green plc (NASDAQ: HTOO) (“Fusion Fuel”), an emerging leader in the green hydrogen sector, today announced financial results for the third quarter ended September 30, 2023. The quarterly shareholder letter is available at https://ir.fusion-fuel.eu/financials-filings/earnings-releases Third Quarter 2023 HighlightsAnnounced long-term green hydrogen supply contract with a Spanish industrial group​ Strategic partnership with Duferco Energia covering Italy, starting with a 1 MW HEVO-Chain Series NC project​ In negotiations with BGR Energy to install 1 MW HEVO-Chain demonstrator in India in 2024​ Announced strategic partnership with Elemental Clean Fuels covering the North American green hydrogen market Received order for 300 kW electrolyzer and balance of...

Continue reading

Nexstim Releases New System Functionalities for Research Use in Europe

Press release, Helsinki, 4 December 2023 at 10 AM (EET) Nexstim Releases New System Functionalities for Research Use in Europe Nexstim Plc (NXTMH:HEX) (“Nexstim” or “Company”) has delivered its first research system module as part of Nexstim NBS (Navigated Brain Stimulation) System 5 with the new functionalities of paired pulse delivery and an EEG user interface. As the new module option is for research use only, it is not CE-marked or FDA cleared but can be used with a customer’s latest versions of NBS System 5 in Europe. The two new product options are called the NBR and TMS-EEG modules. The NBR software enables the delivery of paired pulses, which consist of two biphasic pulses delivered with a short interstimulus interval. Paired pulses can be configured during stimulation mode within the NBR software and stimulation...

Continue reading

Prosafe SE: Commencement of the subscription period in the subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the stock exchange announcement by Prosafe SE (the “Company” or “Prosafe”) on 29 November 2023 announcing the submission of a prospectus dated 29 November 2023 (the “Prospectus”) and the subsequent offering (the “Subsequent Offering”) of up to 1 333 333 new shares (the “Offer Shares”) in the Company, at a subscription price of NOK 60 per share. The subscription period in the Subsequent Offering commences today, on 4 December 2023 at 09:00 hours (CET), and ends on 15 December 2023 at 16:30 hours (CET). The Subsequent...

Continue reading

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Novel ultra-high affinity ligand OncoFAP targets Fibroblast Activation Protein (FAP), associated with a variety of solid tumors Licensing agreement between Philochem and Blue Earth Diagnostics, one of the Bracco family of companies, encompasses applications of OncoFAP for diagnostic and medical imaging Philogen’s Phase I clinical trial with investigational 68Ga-OncoFAP is underway in Europe, with first three patients successfully imaged Blue Earth Diagnostics will assume further clinical development and future commercialization activities of OncoFAP for diagnostic or medical imaging purposes worldwideZURICH, Switzerland and OXFORD, United Kingdom and MONROE TOWNSHIP, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco company and recognized...

Continue reading

NOVONIX Announces Participation in December Investor Events

BRISBANE, Australia, Dec. 04, 2023 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company, today announced that members of the executive team are scheduled to participate in the following upcoming investor events in December 2023:Janney Montgomery Scott Clean Energy Investment Symposium to be held December 5th-6th in New Orleans, LA; Chardan’s Battery Technology Virtual Conference Series to be broadcast Monday, December 11th; and Bank of America Battery Tech Mini-Conference with NOVONIX presenting virtually on Tuesday, December 12th at 11:45 am ESTNOVONIX management will be available to host one-on-one and group investor meetings during the conferences. Presentation materials and available webcast links will be available prior to each event...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.